Login
- Title:
Glycoprotein IIb/IIIa Receptor Inhibition with Abciximab during Percutaneous Coronary Interventions Increases the Risk of Bleeding in Patients with Impaired Renal Function
- Document type:
- Zeitschriftenaufsatz
- Author(s):
- Pinkau, Tobias; Ndrepepa, Gjin; Kastrati, Adnan; Mann, Johannes F.E.; Schulz, Stefanie; Mehilli, Julinda; Schömig, Albert
- Abstract:
- Objective: Whether patients with renal insufficiency (RI) undergoing percutaneous coronary interventions (PCI) benefit from abciximab added to clopidogrel plus aspirin is unknown. Methods: The study included 2,159 patients with coronary artery disease undergoing elective PCI. RI was assessed using glomerular filtration rate (GFR) cutoff values: moderate-to-severe RI (GFR ≤60 ml/min), mild RI (GFR >60 to ≤90 ml/min) and no RI (GFR >90 ml/min). The 30-day incidence of major adverse cardiac events (MACE) and bleeding were the primary outcome analyses. Results: In patients with moderate-to-severe RI, mild RI and no RI, MACE occurred in 5.2, 5 and 2.9%, respectively, in the abciximab group (p = 0.14) and in 4.2, 3.8 and 4.0%, respectively, in the placebo group (p = 0.96). In the abciximab group, bleeding complications occurred in 8.9% of patients with moderate-to-severe RI, in 2.0% with mild RI and in 2.1% with no RI (p < 0.001). Multivariable analysis identified GFR as an independent correlate of MACE (p = 0.03) and bleeding (p = 0.001) with a trend for an interaction between GFR and abciximab regarding major bleeding (p = 0.22). Conclusions: In patients with RI undergoing PCI, adding abciximab to clopidogrel plus aspirin increases the risk of bleeding without benefit in reducing the risk of ischemic complications within the first 30 days.
- Keywords:
- Abciximab; Bleeding; Clopidogrel; Mortality; Percutaneous coronary intervention; Renal insufficiency
- Journal title:
- Cardiology
- Year:
- 2008
- Journal volume:
- 111
- Journal issue:
- 4
- Pages contribution:
- 247--253
- Fulltext / DOI:
- doi:10.1159/000127446
- Publisher:
- S. Karger AG
- Publisher address:
- Basel, Switzerland
- Print-ISSN:
- 1421-9751
- E-ISSN:
- 1421-9751
- Notes:
- Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence and a national licence (funded by the DFG, German Research Foundation) respectively.
BibTeX
Occurrences: